Mukherjee D, Ciaco S, Martinez-Fernandez L, Gavvala K, Bombarda E, Bourdérioux A, Dziuba D, Hanser F, Humbert N, Javed A, Mousli M, Singh P, Tor Y, Improta R, Mori M, Mély Y

Nucleic Acids Res. 2025 09 5;53(17):

UHRF1 poly-auto-ubiquitination induced by the anti-cancer drug, thymoquinone, is involved in the DNA repair machinery recruitment.

Almalki NAR, Sabir JSM, Ibrahim A, Alhosin M, Asseri AH, Albiheyri RS, Zari AT, Bahieldin A, Javed A, Mély Y, Hamiche A, Mousli M, Bronner C

Int J Biochem Cell Biol. 2024 04 20;:106582

Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1.

Ashraf W, Ahmad T, Reynoird N, Hamiche A, Mély Y, Bronner C, Mousli M

Molecules. 2023 08 10;28(16):

Inhibitors of UHRF1 base flipping activity showing cytotoxicity against cancer cells.

Ciaco S, Mazzoleni V, Javed A, Eiler S, Ruff M, Mousli M, Mori M, Mély Y

Bioorg Chem. 2023 05 22;137:106616

Tannin extract from maritime pine bark exhibits anticancer properties by targeting the epigenetic UHRF1/DNMT1 tandem leading to the re-expression of .

Ashraf W, Ahmad T, Almalki NAR, Krifa M, Zaayter L, Pizzi A, Muller CD, Hamiche A, Mély Y, Bronner C, Mousli M

Food Funct. 2021 Dec 13;:

TIP60 governs the auto‑ubiquitination of UHRF1 through USP7 dissociation from the UHRF1/USP7 complex.

Ahmad T, Ashraf W, Ibrahim A, Zaayter L, Muller CD, Hamiche A, Mély Y, Bronner C, Mousli M

Int J Oncol. 2021 Nov;59(5):

S-Protected thiolated nanostructured lipid carriers exhibiting improved mucoadhesive properties.

Arshad S, Masood-Ur-Rehman,Hussain Asim M, Nazir I, Shahzadi I, Mousli M, Bernkop-Schnürch A

Int J Pharm. 2020 09 25;587:119690

A molecular tool targeting the base flipping activity of human UHRF1.

Zaayter L, Mori M, Ahmad T, Ashraf W, Boudier C, Kilin V, Gavvala K, Richert L, Eiler S, Ruff M, Botta M, Bronner C, Mousli M, Mely Y

Chemistry. 2019 Jul 19;:

Coordinated Dialogue between UHRF1 and DNMT1 to Ensure Faithful Inheritance of Methylated DNA Patterns.

Bronner C, Alhosin M, Hamiche A, Mousli M

Genes (Basel). 2019 Jan 18;10(1):

Thymoquinone challenges UHRF1 to commit auto-ubiquitination: a key event for apoptosis induction in cancer cells.

Ibrahim A, Alhosin M, Papin C, Ouararhni K, Omran Z, Zamzami MA, Al-Malki AL, Choudhry H, Mély Y, Hamiche A, Mousli M, Bronner C

Oncotarget. 2018 Jun 19;9(47):28599-28611

Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy.

Choudhry H, Zamzami MA, Omran Z, Wu W, Mousli M, Bronner C, Alhosin M

Oncol Lett. 2018 Jan;15(1):3-10

Interaction of the epigenetic integrator UHRF1 with the MYST domain of TIP60 inside the cell.

Ashraf W, Bronner C, Zaayter L, Ahmad T, Richert L, Alhosin M, Ibrahim A, Hamiche A, Mely Y, Mousli M

J. Exp. Clin. Cancer Res.. 2017 12 21;36(1):188

The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer.

Ashraf W, Ibrahim A, Alhosin M, Zaayter L, Ouararhni K, Papin C, Ahmad T, Hamiche A, Mély Y, Bronner C, Mousli M

Oncotarget. 2017 Aug;8(31):51946-51962

The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer.

Ashraf W, Ibrahim A, Alhosin M, Zaayter L, Ouararhni K, Papin C, Ahmad T, Hamiche A, Mély Y, Bronner C, Mousli M

Oncotarget. 2017 Apr;:

Dynamics of Methylated Cytosine Flipping by UHRF1.

Kilin V, Gavvala K, Barthes NP, Michel BY, Shin D, Boudier C, Mauffret O, Yashchuk V, Mousli M, Ruff M, Granger F, Eiler S, Bronner C, Tor Y, Burger A, Mély Y

J. Am. Chem. Soc.. 2017 Feb;139(6):2520-2528